Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 6/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL23292174 | 0.85 | CYP1A2 (0.46) | CHRM1CHRM4CHRM5CYP1A2TDP1 | |
| Trifluoroacetic Acid SCHEMBL28918734 | 0.84 | ACHE (0.38) | HRH3 | |
| Trifluoroacetic Acid SCHEMBL28709650 | 0.83 | HSD17B10 (0.39) | CHRM1CHRM4CHRM5TSHRHSD17B10 | |
| Trifluoroacetic Acid SCHEMBL30636582 | 0.81 | HSD17B10 (0.42) | POLBTSHRHSD17B10TFPI2HPGD | |
| SCHEMBL273020 | 0.80 | — | — | |
| SCHEMBL29178251 | 0.80 | TDP1 (0.38) | CHRM1CHRM4CHRM5CYP1A2TDP1 | |
| Trifluoroacetic Acid SCHEMBL23932396 | 0.78 | LMNA (0.36) | TSHR | |
| Trifluoroacetic Acid SCHEMBL2265273 | 0.78 | HRH4 (0.39) | CHRM1CHRM4CHRM5CYP1A2TDP1 | |
| Formic Acid SCHEMBL29763161 | 0.78 | CYP1A2 (0.39) | CYP1A2TDP1POLBTSHRHSD17B10 | |
| Trifluoroacetic Acid SCHEMBL28623741 | 0.78 | ALDH1A1 (0.40) | POLBTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115715289-B | Polyarylate and application thereof | 江苏先声药业有限公司 | 2024-12-03 | — | — | CN | disclosed |
| US-20230310445-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | ANOVIA BIOSCIENCES, INC. | 2023-10-05 | — | — | US | disclosed |
| CN-115715289-A | Polyarylate and use thereof | 江苏先声药业有限公司 | 2023-02-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310445-A1 | LOX ENZYME INHIBITING METHODS AND COMPOSITIONS | LOX, LOXL1, LOXL2 | CHRM1 1352/4885CHRM4 1917/4885CHRM5 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.